SG10201602309VA - Taxane and abeo-taxane analogs - Google Patents

Taxane and abeo-taxane analogs

Info

Publication number
SG10201602309VA
SG10201602309VA SG10201602309VA SG10201602309VA SG10201602309VA SG 10201602309V A SG10201602309V A SG 10201602309VA SG 10201602309V A SG10201602309V A SG 10201602309VA SG 10201602309V A SG10201602309V A SG 10201602309VA SG 10201602309V A SG10201602309V A SG 10201602309VA
Authority
SG
Singapore
Prior art keywords
taxane
abeo
analogs
taxane analogs
Prior art date
Application number
SG10201602309VA
Other languages
English (en)
Inventor
James D Mcchesney
John T Henri
Sylesh Kumar Venkataraman
Mahesh Kumar Gundluru
Original Assignee
Arbor Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arbor Therapeutics Llc filed Critical Arbor Therapeutics Llc
Publication of SG10201602309VA publication Critical patent/SG10201602309VA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Epoxy Compounds (AREA)
SG10201602309VA 2011-04-07 2012-04-06 Taxane and abeo-taxane analogs SG10201602309VA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161472968P 2011-04-07 2011-04-07

Publications (1)

Publication Number Publication Date
SG10201602309VA true SG10201602309VA (en) 2016-05-30

Family

ID=48781786

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201602309VA SG10201602309VA (en) 2011-04-07 2012-04-06 Taxane and abeo-taxane analogs
SG2013074919A SG194128A1 (en) 2011-04-07 2012-04-06 Taxane and abeo-taxane analogs

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2013074919A SG194128A1 (en) 2011-04-07 2012-04-06 Taxane and abeo-taxane analogs

Country Status (10)

Country Link
US (1) US8912229B2 (cg-RX-API-DMAC7.html)
EP (1) EP2694055A4 (cg-RX-API-DMAC7.html)
JP (1) JP5970536B2 (cg-RX-API-DMAC7.html)
KR (1) KR20140048113A (cg-RX-API-DMAC7.html)
CN (1) CN103764138A (cg-RX-API-DMAC7.html)
AU (1) AU2012364858A1 (cg-RX-API-DMAC7.html)
CA (1) CA2832596A1 (cg-RX-API-DMAC7.html)
MX (1) MX2013011694A (cg-RX-API-DMAC7.html)
SG (2) SG10201602309VA (cg-RX-API-DMAC7.html)
WO (1) WO2013106029A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101444693B1 (ko) 2011-06-06 2014-09-26 아버 테라퓨틱스 엘엘씨 암 화학요법제의 산에 불안정한 친유성 전구약물
CN104650109B (zh) * 2013-11-22 2019-01-01 江苏天士力帝益药业有限公司 紫杉烷类化合物
CA3199171A1 (en) 2020-11-19 2022-05-27 Spexis Ag Pharmaceutical combinations comprising a peptide cxcr4 inhibitor and a taxane for treating cancer
EP4000613A1 (en) 2020-11-19 2022-05-25 Polyphor Ag Pharmaceutical combinations comprising a peptide cxcr4 inhibitor and a taxane for treating cancer
EP4223292A1 (en) 2022-02-07 2023-08-09 Cellestia Biotech AG Pharmaceutical combinations for treating cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021173A1 (en) * 1992-04-17 1993-10-28 Abbott Laboratories Taxol derivatives
AU2004275881A1 (en) * 2003-09-25 2005-04-07 Tapestry Pharmaceuticals, Inc. 9,10-alpha,alpha-OH-taxane analogs and methods for production thereof
WO2008121476A1 (en) * 2007-03-28 2008-10-09 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
WO2008109360A1 (en) * 2007-02-28 2008-09-12 Tapestry Pharmaceuticals, Inc Taxane analogs for the treatment of brain cancer
US20080207743A1 (en) * 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment
WO2011028571A1 (en) * 2009-09-01 2011-03-10 Tapestry Pharmaceuticals, Inc. Taxane analogues, their use, pharmaceutical compositions containing them, and processes for their preparation

Also Published As

Publication number Publication date
US20140093503A1 (en) 2014-04-03
US8912229B2 (en) 2014-12-16
EP2694055A1 (en) 2014-02-12
CA2832596A1 (en) 2013-07-18
JP2014512362A (ja) 2014-05-22
AU2012364858A1 (en) 2013-11-21
CN103764138A (zh) 2014-04-30
MX2013011694A (es) 2014-05-27
SG194128A1 (en) 2013-11-29
JP5970536B2 (ja) 2016-08-17
EP2694055A4 (en) 2014-09-10
NZ617430A (en) 2016-05-27
WO2013106029A1 (en) 2013-07-18
KR20140048113A (ko) 2014-04-23

Similar Documents

Publication Publication Date Title
IL230511A0 (en) 4-Imidazopyridazine-1-yl-benzamides and 4-imidazotriazine-1-yl-benzamides as btk inhibitors
ZA201401603B (en) Novel clucagon analogues
PL3075273T3 (pl) Część składowa inhalatora
PL3305106T3 (pl) Część składowa inhalatora
PL3701800T3 (pl) Zastosowanie
AU338419S (en) Dumbell
IL229243B (en) Complementary factor b analogs and their uses
AP2014007621A0 (en) 2-Thiopyrimidinones
EP2774642A4 (en) SYRINGE
GB201404963D0 (en) Game entry
EP2694055A4 (en) ANALOGUES OF TAXANE AND ABÉO-TAXANE
GB201118334D0 (en) Novel dosage form
PL2729222T3 (pl) Lotka
GB201120123D0 (en) Dental insrument
GB201109834D0 (en) Rucksack
GB2490723B (en) Modified syringe
GB2497691B (en) Game device
GB201118802D0 (en) Game
GB201115238D0 (en) Pit-stop easy
PT2734522T (pt) 4-imidazopiridazina-1-il-benzamidas e 4-imidazotriazin-1- il-benzamidas como inibidores de btk
GB201102529D0 (en) Fine B-Day
GB201121138D0 (en) Placement game
GB201107384D0 (en) Jewelled wellys
GB201109368D0 (en) Eyeliner effect
GB201216534D0 (en) Games